Sonny Hsiao, Acepodia CEO
Acepodia's off-the-shelf cell therapies get another $100M for oncology trials
California and Taipei biotech Acepodia has lined up another six-figure funding round to take its off-the-shelf cell therapies forward.
Spun out of Nobel laureate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
